Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

cefTRIAXone

cefTRIAXone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Rocephin POWDER FOR INJECTION, INJECTABLE 250 mg, 500 mg, 1 g, 2 g, 10 g      


Comments:

Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines

Monitor for calcium interaction, notify MD of interaction if suspected.


All pediatric patients will have I.M. cefTRIAXone diluted with 1% lidocaine, unless the physician specifically writes otherwise. cefTRIAXone is not recommended in patients less than one month of age.


Last updated: Dec. 19, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.